• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    FILE - In this undated file photo provided by Kentucky BioProcessing, tobacco plants are grown in a controlled environment at the Kentucky BioProcessing facility in Owensboro, Ky. The company is using tobacco plants grown at this facility to help manufacture an experimental drug to treat patients infected with Ebola. An experimental Ebola drug healed all 18 monkeys infected with the deadly virus in a study released Friday, Aug. 29, 2014. (AP Photo/Kentucky BioProcessing, File)
    Business

    Experimental Ebola drug heals all monkeys in study

    Marilynn Marchione -
    August 29, 2014 9:03 pm
    0
    FDA approves Biogen’s MS drug Plegridy
    Business

    FDA approves Biogen’s MS drug Plegridy

    Washington Examiner -
    August 15, 2014 11:27 pm
    0
    Alabama high court upholds generic drug decision
    Business

    Alabama high court upholds generic drug decision

    Washington Examiner -
    August 15, 2014 8:47 pm
    0
    FDA clears Avastin for late-stage cervical cancer
    Business

    FDA clears Avastin for late-stage cervical cancer

    Washington Examiner -
    August 15, 2014 5:48 pm
    0
    $580 million EU antitrust fine for drug makers
    Business

    $580 million EU antitrust fine for drug makers

    Washington Examiner -
    July 9, 2014 9:59 am
    0
    It's no surprise the manufacturers and sellers of sterilization and contraception have lobbied on the Obama administration's contraception mandate, backed the Obamacare law Obama uses to justify the mandate, and fought for Obama's election and re-election. (iStock Photo)
    Beltway Confidential

    The drug lobby vs. Hobby Lobby: Pharma lobbyists and the contraception mandate

    Timothy P. Carney -
    June 30, 2014 8:44 am
    0
    (Thinkstock)
    Columnists

    Who should have say on a patient taking experimental drugs?

    Walter Williams -
    June 9, 2014 3:52 pm
    0
    City of Chicago sues over painkiller marketing

    City of Chicago sues over painkiller marketing

    Carla Johnson -
    June 3, 2014 11:34 pm
    0
    Drug makers are under fire as the $84,000 price tag on a new hepatitis medicine has galvanized the debate over prescription drug costs. But the pharmaceutical industry could be mounting a much stronger defense if it weren't haunted by its support for government health care. (Thinkstock Image)
    Columnists

    Pharmaceutical industry haunted by support for government health care

    Philip Klein -
    May 29, 2014 9:56 pm
    0
    In this May 4, 2014 photo, the Pfizer logo is displayed on the exterior of a former Pfizer factory  in the Brooklyn borough of New York. Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca. The Monday, May 26, 2014 announcement comes a week after AstraZeneca's board rejected a proposed $119 billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue. (AP Photo/Mark Lennihan, File)
    Business

    Pfizer pulls plug on push to buy AstraZeneca

    Alex Veiga -
    May 26, 2014 6:29 pm
    0
    1...150151152...159Page 151 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.